CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: polyether
Accession: CHEBI:46774
browse the term
Definition: Any ether that contains more than one ether linkage.
Synonyms: related_synonym: polyethers
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
[Verapamil results in decreased activity of ABCB1 protein] which affects the transport of Digoxin
CTD
PMID:20510202
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions
EXP
[Verapamil results in decreased activity of ABCB1 protein] which affects the transport of Digoxin
CTD
PMID:20510202
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
499
chemical entity
499
atom
499
nonmetal atom
492
oxygen atom
448
oxygen molecular entity
448
organooxygen compound
428
ether
59
polyether
1
(R)-laudanosine
0
(S)-glaucine +
0
1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline +
0
1-amino-15-oxo-4,7,10-trioxa-14-azaoctadecan-18-oic acid
0
1-ethoxy-2-(2-ethoxyethoxy)ethane
0
2,2-dimethyl-3,6,9,12,15-pentaoxa-2-silahexadecane
0
2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile +
1
2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl]amino\}-2-(propan-2-yl)pentanenitrile +
0
3,6,9,12,15,18-hexaoxaicosane
0
3,6,9,12,15-pentaoxaheptadecane
0
7-amino-1-(5-nitro-2-furyl)-1,8-dioxo-11,14,17,20,23-pentaoxa-2-azahexacosan-26-amide
0
GCB
0
Jeffamine ED-2001
0
Jeffamine M-600
0
N(2)-[3-(2-\{2-[(\{1-[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]piperidin-4-yl\}carbonyl)amino]ethoxy\}ethoxy)propanoyl]-N(6)-(5-nitro-2-furoyl)lysinamide
0
N(2)-\{3-[2-(2-\{[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]amino\}ethoxy)ethoxy]propanoyl\}-N(6)-(5-nitro-2-furoyl)lysinamide
0
N(2)-\{3-[2-(2-\{[(1-\{N-[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]glycyl\}piperidin-4-yl)carbonyl]amino\}ethoxy)ethoxy]propanoyl\}-N(6)-(5-nitro-2-furoyl)lysinamide
0
N-(18-amino-18-oxo-3,6,9,12,15-pentaoxaoctadec-1-yl)-N(2)-\{3-[2-(2-\{[(1-\{[1-(\{1-[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]piperidin-4-yl\}carbonyl)piperidin-4-yl]carbonyl\}piperidin-4-yl)carbonyl]amino\}ethoxy)ethoxy]propanoyl\}-N(6)-(5-nitro-2-furoyl)lysinamide
0
N-\{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl\}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide
0
N-\{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl\}-26-(indol-3-yl)-23-oxo-4,7,10,13,16,19-hexaoxa-22-azahexacosan-1-amide
0
N-\{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl\}-32-(indol-3-yl)-29-oxo-4,7,10,13,16,19,22,25-octaoxa-28-azadotriacontan-1-amide
0
N-\{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl\}-80-(indol-3-yl)-77-oxo-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73-tetracosaoxa-76-azaoctacontan-1-amide
0
N-deethylaconine
0
O-(2-aminopropyl)-O'-(2-methyoxyethyl)octa(propylene glycol)
0
Src Inhibitor-1
0
Src Inhibitor-5
0
ZM447439
0
aconine
0
benzoylaconine
0
benzoylhypaconine
0
benzoylmesaconine
0
bianfugenine
0
chasmanine
0
crassicauline A
0
crown ether +
0
deoxyaconitine
0
diether +
0
diglyme
0
eribulin
0
florbetaben ((18)F)
0
foresaconitine
0
foresticine
0
hexamidine
0
hokbusine A
0
hydroxypolyether +
0
hypaconine
0
linkable staurosporine analogue
0
mesaconine
0
naloxegol
0
neojiangyouaconitine
0
neoline
0
oxonitine
0
pectenotoxin-11
0
pentaglyme
0
poly(ethylene glycol) derivative +
0
propamidine
0
sinomendine
0
syringaresinol +
0
tetraglyme
0
thalicpureine
0
triglyme
0
yunaconitine
0
zilucoplan
0
Path 2
CHEBI ontology
499
subatomic particle
499
composite particle
499
hadron
499
baryon
499
nucleon
499
atomic nucleus
499
atom
499
main group element atom
492
p-block element atom
492
carbon group element atom
481
carbon atom
480
organic molecular entity
480
heteroorganic entity
476
organochalcogen compound
430
organooxygen compound
428
ether
59
polyether
1
(R)-laudanosine
0
(S)-glaucine +
0
1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline +
0
1-amino-15-oxo-4,7,10-trioxa-14-azaoctadecan-18-oic acid
0
1-ethoxy-2-(2-ethoxyethoxy)ethane
0
2,2-dimethyl-3,6,9,12,15-pentaoxa-2-silahexadecane
0
2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile +
1
2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl]amino\}-2-(propan-2-yl)pentanenitrile +
0
3,6,9,12,15,18-hexaoxaicosane
0
3,6,9,12,15-pentaoxaheptadecane
0
7-amino-1-(5-nitro-2-furyl)-1,8-dioxo-11,14,17,20,23-pentaoxa-2-azahexacosan-26-amide
0
GCB
0
Jeffamine ED-2001
0
Jeffamine M-600
0
N(2)-[3-(2-\{2-[(\{1-[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]piperidin-4-yl\}carbonyl)amino]ethoxy\}ethoxy)propanoyl]-N(6)-(5-nitro-2-furoyl)lysinamide
0
N(2)-\{3-[2-(2-\{[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]amino\}ethoxy)ethoxy]propanoyl\}-N(6)-(5-nitro-2-furoyl)lysinamide
0
N(2)-\{3-[2-(2-\{[(1-\{N-[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]glycyl\}piperidin-4-yl)carbonyl]amino\}ethoxy)ethoxy]propanoyl\}-N(6)-(5-nitro-2-furoyl)lysinamide
0
N-(18-amino-18-oxo-3,6,9,12,15-pentaoxaoctadec-1-yl)-N(2)-\{3-[2-(2-\{[(1-\{[1-(\{1-[(1-\{3-[2-(2-\{[4-(indol-3-yl)butanoyl]amino\}ethoxy)ethoxy]propanoyl\}piperidin-4-yl)carbonyl]piperidin-4-yl\}carbonyl)piperidin-4-yl]carbonyl\}piperidin-4-yl)carbonyl]amino\}ethoxy)ethoxy]propanoyl\}-N(6)-(5-nitro-2-furoyl)lysinamide
0
N-\{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl\}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide
0
N-\{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl\}-26-(indol-3-yl)-23-oxo-4,7,10,13,16,19-hexaoxa-22-azahexacosan-1-amide
0
N-\{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl\}-32-(indol-3-yl)-29-oxo-4,7,10,13,16,19,22,25-octaoxa-28-azadotriacontan-1-amide
0
N-\{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl\}-80-(indol-3-yl)-77-oxo-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73-tetracosaoxa-76-azaoctacontan-1-amide
0
N-deethylaconine
0
O-(2-aminopropyl)-O'-(2-methyoxyethyl)octa(propylene glycol)
0
Src Inhibitor-1
0
Src Inhibitor-5
0
ZM447439
0
aconine
0
benzoylaconine
0
benzoylhypaconine
0
benzoylmesaconine
0
bianfugenine
0
chasmanine
0
crassicauline A
0
crown ether +
0
deoxyaconitine
0
diether +
0
diglyme
0
eribulin
0
florbetaben ((18)F)
0
foresaconitine
0
foresticine
0
hexamidine
0
hokbusine A
0
hydroxypolyether +
0
hypaconine
0
linkable staurosporine analogue
0
mesaconine
0
naloxegol
0
neojiangyouaconitine
0
neoline
0
oxonitine
0
pectenotoxin-11
0
pentaglyme
0
poly(ethylene glycol) derivative +
0
propamidine
0
sinomendine
0
syringaresinol +
0
tetraglyme
0
thalicpureine
0
triglyme
0
yunaconitine
0
zilucoplan
0